Covered recipient · General Payments record
JOSE M LOPEZ
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$11,941.00
- Reported across 294 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,040.00 | 1 |
| Travel and Lodging | $848.02 | 5 |
| Food and Beverage | $494.73 | 25 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $8,037.67 | 11 |
| PFIZER INC. | $77.56 | 5 |
| Novo Nordisk AS | $56.27 | 4 |
| Exact Sciences Corporation | $53.69 | 2 |
| Astellas Pharma US Inc | $22.16 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $19.80 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.87 | 1 |
| Merck Sharp & Dohme Corporation | $18.06 | 1 |
| Amgen Inc. | $17.42 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.50 | 1 |
| ABBVIE INC. | $15.34 | 1 |
| Acerta Pharma LLC | $14.76 | 1 |
| Dynavax Technologies Corporation | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.34 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997790545 | CMS |
| Amgen Inc. | $17.42 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020608041 | CMS |
| Astellas Pharma US Inc | $22.16 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034210977 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.76 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011947741 | CMS |
| Dynavax Technologies Corporation | $14.65 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 985819867 | CMS |
| Eisai Inc. | $267.80 | 01/20/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1023316521 | CMS |
| Eisai Inc. | $68.28 | 01/20/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1023316527 | CMS |
| Eisai Inc. | $22.63 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023316531 | CMS |
| Eisai Inc. | $421.49 | 01/20/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1023316535 | CMS |
| Eisai Inc. | $50.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023316519 | CMS |
| Eisai Inc. | $14.52 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023316523 | CMS |
| Eisai Inc. | $50.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023316529 | CMS |
| Eisai Inc. | $64.00 | 01/21/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1023316533 | CMS |
| Eisai Inc. | $12.50 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023316537 | CMS |
| Eisai Inc. | $26.45 | 01/22/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1023316517 | CMS |
| Eisai Inc. | $7,040.00 | 02/24/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1023316525 | CMS |
| Exact Sciences Corporation | $22.30 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026564943 | CMS |
| Exact Sciences Corporation | $31.39 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026564991 | CMS |
| Merck Sharp & Dohme LLC | $18.06 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048272365 | CMS |
| Novo Nordisk Inc | $14.58 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001728651 | CMS |
| Novo Nordisk Inc | $13.30 | 04/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001728633 | CMS |
| Novo Nordisk Inc | $13.55 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001728643 | CMS |
| Novo Nordisk Inc | $14.84 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001728661 | CMS |
| PFIZER INC. | $16.89 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049791597 | CMS |
| PFIZER INC. | $16.27 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050512917 | CMS |
| PFIZER INC. | $13.99 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049139887 | CMS |
| PFIZER INC. | $16.79 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049616785 | CMS |
| PFIZER INC. | $13.62 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050667113 | CMS |
| Tactile Systems Technology Inc | $19.80 | 05/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020839513 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.87 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055461187 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.50 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056471991 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.